Home
Storia in 2 fonti
New GLP1 pill helps patients lose up to 8% of body weight, trial shows
Daily orforglipron tablets led to greater weight loss than semaglutide tablets, offering potential oral alternative to Wegovy and Mounjaro
- ·
theguardian.com
New GLP1 pill helps patients lose up to 8% of body weight, trial shows
Daily orforglipron tablets led to greater weight loss than semaglutide tablets, offering potential oral alternative to Wegovy and Mounjaro
- ·
ilmessaggero.it
Perdere peso senza iniezioni? La nuova pillola GLP-1 promette fino all'8% di dimagrimento. Cosa sappiamo
Una nuova pillola giornaliera a base di GLP-1, chiamata orfoglipron e sviluppata da Eli Lilly, potrebbe offrire un’alternativa orale più efficace alla semaglutide in compresse per…